ASVRX | FCVAX | ASVRX / FCVAX | |
Total Expense Ratio | 1.59 | 1.26 | 126% |
Annual Report Gross Expense Ratio | 1.59 | 1.26 | 126% |
Fund Existence | 15 years | 21 years | - |
Gain YTD | -2.851 | 2.495 | -114% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.66B | 4.42B | 105% |
Annual Yield % from dividends | 0.42 | 0.33 | 128% |
Returns for 1 year | -8.27 | -2.38 | 348% |
Returns for 3 years | 6.11 | 10.53 | 58% |
Returns for 5 years | 62.47 | 68.74 | 91% |
Returns for 10 years | 13.00 | 9.78 | 133% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TQVIX | 18.51 | 0.09 | +0.49% |
T. Rowe Price Integrated US LCV Eq I | |||
PSIFX | 48.07 | 0.19 | +0.40% |
PGIM Quant Solutions Large-Cap Index Z | |||
MADVX | 20.77 | 0.03 | +0.14% |
BlackRock Equity Dividend Instl | |||
YAFIX | 20.56 | -0.06 | -0.29% |
AMG Yacktman Focused I | |||
OSPPX | 6.55 | -0.02 | -0.30% |
Invesco SteelPath MLP Alpha Plus R6 |